Edgewise Therapeutics, Inc.
EWTX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$134 | -$100 | -$68 | -$43 |
| Dep. & Amort. | $2 | $2 | $1 | $0 |
| Deferred Tax | $0 | $0 | $0 | -$2 |
| Stock-Based Comp. | $25 | $18 | $11 | $4 |
| Change in WC | $10 | -$2 | $4 | $5 |
| Other Non-Cash | -$13 | -$10 | -$1 | $2 |
| Operating Cash Flow | -$109 | -$92 | -$53 | -$34 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$6 | -$6 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$477 | -$256 | -$292 | -$288 |
| Inv. Sales/Matur. | $294 | $364 | $227 | $47 |
| Other Inv. Act. | $0 | $0 | -$0 | -$0 |
| Investing Cash Flow | -$185 | $103 | -$71 | -$242 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $239 | $53 | $129 | $186 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $10 | $1 | $0 | $0 |
| Financing Cash Flow | $249 | $53 | $130 | $186 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$44 | $64 | $6 | -$89 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $86 | $22 | $16 | $105 |
| End Cash | $42 | $86 | $22 | $16 |
| Free Cash Flow | -$110 | -$98 | -$58 | -$34 |